Research field (2):
Neurology
, Experimental pathology
Research keywords (3):
神経病理
, アルツハイマー病
, 包括脳ネットワーク
Research theme for competitive and other funds (1):
2022 - 2025 心房細動アブレーションによる洞調律化が認知機能に与える効果の解明
Papers (33):
Yoshiki Niimi, Shorena Janelidze, Kenichiro Sato, Naoki Tomita, Tadashi Tsukamoto, Takashi Kato, Kenji Yoshiyama, Hisatomo Kowa, Atsushi Iwata, Ryoko Ihara, et al. Combining plasma Aβ and p-tau217 improves detection of brain amyloid in non-demented elderly. Alzheimer's research & therapy. 2024. 16. 1. 115-115
Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara, Kazushi Suzuki, Atsushi Iwata, Takeshi Iwatsubo. Simplifying Alzheimer's Disease Monitoring: A Novel Machine-Learning Approach to Estimate the Clinical Dementia Rating Sum of Box Changes Using the Mini-Mental State Examination and Functional Activities Questionnaire. Journal of Alzheimer's disease : JAD. 2024
Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara, Atsushi Iwata, Takeshi Ikeuchi, Takeshi Iwatsubo. Advertisement by medical facilities as an opportunity route of APOE genetic testing in Japan: a website analysis. Journal of community genetics. 2024
Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara, Kazushi Suzuki, Atsushi Iwata, Takeshi Iwatsubo. APOE-ε4 allele[s]-associated adverse events reported from placebo arm in clinical trials for Alzheimer's disease: implications for anti-amyloid beta therapy. Frontiers in Dementia. 2024. 2
井原 涼子, 岩田 淳. タウを標的とする疾患修飾薬の開発状況-Recent updates on the development of disease modifying therapies targeting tau-特集 認知症の薬物治療. 臨床精神薬理 = Japanese journal of clinical psychopharmacology. 2023. 26. 2. 149-154
井原 涼子. 臨床研究と診療におけるバイオマーカー結果開示の実際と課題-Experiences and challenges in disclosing Alzheimer's disease biomarker results in clinical research and clinical practice-特集 バイオマーカー結果開示をめぐる諸問題. Dementia Japan : 日本認知症学会誌 / 日本認知症学会誌編集委員会 編. 2023. 37. 1. 47-53